Hamilton James C sold ARWR

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001830755-26-000007

Machine-readable

Structured copy

Timestamps

Event (reported)

Apr 23, 2026

Published

Apr 24, 2026

Ingested by INSIDER

Nov 5, 04:02 UTC

Last re-read

Nov 5, 04:02 UTC

Extracted facts

Filer

Hamilton James C

Role

Chief Medical Officer

Transaction

Open-market saleAs filed: “S”

Asset

ARROWHEAD PHARMACEUTICALS, INC.

Ticker

ARWR

Shares

10.0K

Price per share

$75

Value

$750,000

Execution date (reported)

Apr 23, 2026

Owned after transaction

227.0K shares

Rule 10b5-1 plan

Yes, as checked by the filer

Days from execution to publication

1

Calculation

What this establishes

Hamilton James C filed this Form 4 reporting a open-market sale of ARWR on Apr 23, 2026. It became public on Apr 24, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Chief Medical Officer

Hamilton James Ccik:0001830755

Issuer

ARROWHEAD PHARMACEUTICALS, INC.cik:0000879407

Revision history · 0

No field has changed since this record was first ingested.